The role of the hypothalamus-pituitary-adrenal (HPA) axis in regulating the growth ofMycobacterium avium in Mycobacterium bovis BCG-resistant and -susceptible congenic mice was evaluated. Restraint was used to activate the HPA axis, which resulted in an increase in the level of corticosterone in the plasma. Activation of the HPA axis increased the susceptibility of BALB/c.Bcg' mice to the growth of M. avium. In contrast, the growth of M. avium was not altered in BALB/c.Bcg' mice as a result of HPA activation. Adrenalectomy abolished the effect of HPA activation on mycobacterial growth, as did treatment of the mice with a glucocorticoid receptor antagonist, RU 486. Activation of the HPA axis also resulted in the increased susceptibility of splenic macrophages from Bcgj mice but not from Bcg' mice to M. avium growth in vitro. The production of tumor necrosis factor alpha and of reactive nitrogen intermediates by splenic macrophages from both strains of mice was suppressed as a result of HPA activation. The implications of these findings for resistance controlled by Bcg and for susceptibility to mycobacterial growth are discussed.
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The incidence of mycobacterial diseases has increased dramatically in the United States during the past 10 years (6, 28) . An increase in Mycobacterium avium infections has occurred largely because of infection by the human immunodeficiency virus. While approximately 50% of the increased incidence in Mycobacterium tuberculosis can also be attributed to human immunodeficiency virus infection, infection of individuals who are not infected with human immunodeficiency virus has also increased significantly. The susceptibility of humans to mycobacterial disease is determined, in part, by genetic differences (13, 47, 51, 52) but is also affected by their environment. Homelessness and malnutrition (7, 26) are two cofactors that can contribute to the likelihood of mycobacterial infection. Additional factors such as ageing, chronic alcoholism, and stress have also been cited as being associated with activation of mycobacterial disease (11, 16, 22, 24, 33, 35, 37, 39, 58) .
In mice, the genetic resistance to the in vivo growth of mycobacteria has been shown to be controlled by a gene, termed Bcg, which maps to chromosome 1 (48) . A syntenic group of genes maps to human chromosome 2q in humans (47) . We have reported that macrophages from congenic Bcgr and Bcgj mice express major histocompatibility complex (MHC) class II glycoproteins differently. Thus, macrophages from Bcgr mice can be induced to persistently express I-A, while macrophages from Bcgj mice will only transiently express I-A (25, 63) . In subsequent studies, we reported that I-A expression by macrophages from the Bcgs mice was suppressed by activation of the hypothalamicpituitary-adrenal (HPA) axis as a result of a stressor, physical restraint (60, 62) . In contrast, I-A expression by macrophages from the Bcgr mice was not affected by HPA axis activation. Together, these observations suggested that my-* Corresponding author. cobacterial growth that is controlled by Bcg may also be differentially affected by HPA axis activation.
The purpose of this investigation was to explore the role of the HPA axis in regulating the growth of M. avium in congenic Bcg' and Bcg' mice. We found that activation of the HPA axis by restraint increased the susceptibility ofBcg' mice to mycobacterial growth but did not affect the ability of Bcg' mice to limit the growth of the mycobacteria. The suppressive effects of HPA axis activation also resulted in an increased susceptibility to mycobacterial growth within macrophages from the Bcgj mice. The effect of HPA axis activation on the in vivo growth of the mycobacteria was abrogated by adrenalectomy and by treatment of mice with the glucocorticoid receptor antagonist RU 486. Activation of the HPA axis resulted in a suppression of tumor necrosis factor alpha (TNF-a) and reactive nitrogen intermediates produced by macrophages from both Bcg' and Bcgj mice.
MATERIALS AND METHODS
Animals. Male BALB/c.Bcg' mice were obtained at 6 weeks of age from Harlan-Sprague-Dawley (Indianapolis, Ind.). The mice were housed in groups of five in PCS-80 laminar flow isolation cages (Lab Products, Inc., Maywood, N.J.). The mice were given food and water ad libitum and acclimated to their housing environment prior to the initiation of all experiments. Adrenalectomized and sham adrenalectomized mice were also obtained from Harlan-SpragueDawley. Adrenalectomized mice were then maintained on 1% saline in drinking water. BALB/c.Bcg' mice were provided by Michael Potter (National Cancer Institute [NCI]) (38) and bred in our animal facility. Male mice were used at 6 to 8 weeks of age.
HPA activation via restraint stress. To activate the HPA axis, the mice were restrained as described by Zwilling et al. (60) . Briefly, the mice were placed individually into 50-ml conical centrifuge tubes which were punctured to allow for ventilation and to prevent hyperthermia. The tubes allow for limited forward and backward movement. The mice were maintained horizontally in tubes for single or multiple 18-h restraint cycles. Mice were restrained prior to the initiation of the dark (6-p.m.) phase of the 12-h day-night cycle and removed the following morning at the conclusion of the 18-h stress period. Following one or five 18-h restraint cycles, the mice were returned to their standard housing and then sacrificed 12 days after the initiation of the experiment. The mice that received 10 restraint cycles were restrained initially for 5 consecutive cycles, returned to their standard housing for 2 days, and then restrained again for another 5 consecutive cycles. The mice were then sacrificed immediately after the last restraint on day 12. Control transported mice were housed in groups of five and deprived of both food and water during periods in which the experimental mice were being restrained. Conventionally housed mice served as an additional control.
Administration of RU 486 (Mifepristone). The glucocorticoid receptor antagonist RU 486 (36) was kindly provided by Roussel-Uclaf (Romainville, France). RU 486 was dissolved in polyethylene glycol (molecular weight, 400) and injected subcutaneously at a dose of 25 mg/kg of body weight daily, beginning at 2 days prior to the initiation of restraint and continuing throughout the entire restraint period. Control mice were injected with equal volumes of the vehicle.
Hormone replacement therapy. Time release pellets (Innovative Research of America, Toledo, Ohio) were asceptically inserted through 5-mm incisions on the backs of the animals. The incisions were treated with topical antibiotics and sutured. To achieve basal hormone levels, pellets containing either 0.001 mg of epinephrine, 5 ,ug of d-aldosterone, and 0.5 mg of corticosterone were implanted (19) . To achieve corticosterone levels consistent with those found following HPA axis activation, pellets containing 15 10 18-h cycles after infection with 5 x 104 CFU of M. avium. The numbers of CFU in the spleens (A) and lungs (B) were determined 12 days after injection of the mycobacteria. The numbers of CFU isolated from the spleens and lungs prior to restraint were 13,519 CFU/g of spleen per g of body weight and 584 CFU/g of lung per g of body weight, respectively. The data are the means ± standard deviations (SD) for seven animals per group. The differences between 5-and 10-cycle restraint and control mice were significant by analysis of variance (P < 0.001).
ination of residual plots did not contradict the validity of the methods used. Finally, reports of the pairwise comparison of treatment groups were made by the least significant difference post-hoc test. Levels of ACIH in plasma in the in vivo experiments, as well as the nitric oxide and TNF-a measurements on the independent replications in the in vitro experiments, were similarly analyzed, with the exception that these analyses were on the absolute scale. Levels of corticosterone in the plasma of the adrenalectomized mice with placebo or with low-dose corticosterone implants were all lower than the assay limit of 25 ng/ml. These data were conservatively analyzed by using the worse-case value (i.e., at worst, our declarations of significance are understated).
RESULTS
The susceptibility to mycobacterial growth of Bcg' mice by HPA axis activation by restraint correlated with its duration (Fig. 1) . HPA axis activation for 5 or 10 daily 18-h cycles of restraint resulted in a significant (P < 0.001) 19 ,462 CFU/g of spleen per g of body weight and 18,083 CFU/g of spleen per g of body weight, respectively. The data are the means + SD for seven animals per group. The difference between the values for the restraint and control groups of Bcg' mice was significant (P < 0.001). The difference between the growth of the mycobacteria in the spleens of Bcg' mice versus growth in those of Bcg' mice was also significant (P < 0.001). Similar observations were made concerning differences in the effect of HPA activation on growth of the mycobacteria in the lungs (data not shown).
increase in mycobacterial growth (Fig. 1A) . The number of CFU isolated from the spleens of mice restrained for 10 cycles was 138,000 CFU/g of spleen per g of body weight. In contrast, only 72,000 CFU/g of spleen per g of body weight were isolated from control mice. Similar observations were made following enumeration of mycobacterial growth in the lungs (Fig. 1B) .
Differential effects of HPA axis activation on congenic BALB/ciBcgr and BALB/c.Bcg' mice. When we compared the effects of HPA axis activation on mycobacterial growth in Bcg' and Bcg' mice, we found that restraint resulted in a significant increase (P < 0.001) in the number of mycobacterial CFU isolated from the spleens ofBcg' mice but did not affect the growth of the microorganisms in the spleens of Bcg' mice (Fig. 2) . Thus, the mycobacteria isolated from the spleens of Bcg' mice increased from 100,000 CFU in control mice to more then 175,000 CFU following restraint. In contrast, the number of CFU isolated from the spleens of Bcg' mice remained at about 40,000. The data in Fig. 2 32 ,081 CFU/g of spleen per g of body weight and 33,484 CFU/g of spleen per g of body weight, respectively. The number of CFU from the lungs of adrenalectomized mice was 782 CFU/g of lung per g of body weight, and the number of CFU from the lungs of untreated mice was 807 CFU/g of lung per g of body weight. The data are the means + SD for seven animals per group. The effect of HPA activation was significant (P < 0.001). The effect of restraint in adrenalectomized mice was not significant, i.e., adrenalectomy abrogated the effect of restraint. The effect of implantation of time release pellets containing high doses of corticosterone on mycobacterial growth was significant (P < 0.001).
spleens of adrenalectomized mice that received basal-level replacement of d-aldosterone and epinephrine but that had elevated levels of corticosterone. The results in Fig. 4A show that adrenalectomy resulted in decreased levels of corticosterone in the plasma of restrained mice compared with those in control and sham-adrenalectomized mice. In contrast, the levels of ACIH in the mice with high levels of corticosterone were suppressed (Fig. 4B) in the plasma of mice with low levels of corticosterone. The use of time release pellets that yielded a high level of corticosterone resulted in low levels of ACIH and increased the susceptibility to mycobacterial growth (Fig. 3) . Implantation of time release pellets containing high levels of corticosterone into Bcg' mice failed to alter the growth pattern of the mycobacteria. Thus, despite the high levels of corticosterone in the plasma of these mice, no difference in the growth of the mycobacteria between mice receiving pellets containing high levels of corticosterone and those receiving placebo pellets was observed (data not shown).
The glucocorticoid receptor antagonist RU 486 abrogates the effect of restraint-mediated HPA activation. To directly implicate the high levels of corticosterone that resulted from activation of the HPA axis, mice were injected with the glucocorticoid receptor antagonist RU 486. The results in Fig. 5 6 show that activation of the HPA axis by restraint resulted in a significant increase (P < 0.001) in mycobacterial growth in macrophages from BALB/c.Bcg' mice. In contrast, the growth of M. avium in macrophages from BALB/c.Bcg' mice was not affected by HPA axis activation.
Macrophage TNF-a and NO production is suppressed by HPA activation. An antimicrobial effector pathway that has been shown to be important in the control of mycobacterial growth in mice is the IFN--y-dependent, TNF-a-induced production of reactive nitrogen intermediates (9, 18) . Activation of the HPA axis by restraint resulted in a suppression of TNF-a production following stimulation of splenic macrophages from restrained Bcgr and Bcgj mice with rIFN-y and LPS (Fig. 7) . The amount of TNF-a was reduced from 1,798 pg/ml produced by macrophages from Bcgj control mice to 1,035 pg/ml produced by the splenic macrophages following activation of the HPA axis (P < 0.002). The effect of HPA axis activation on TNF-a production by macrophages from Bcgr mice was less than that observed for macrophages from Bcgj mice. NO production was also reduced from 40 to 16 ,M following restraint (Fig. 8) . HPA axis activation also resulted in a decrease in the production of TNF-a and of reactive nitrogen intermediates by macrophages from the Bcgj mice.
DISCUSSION
The results of this investigation show that activation of the HPA axis can increase the susceptibility of mice to mycobacterial growth. This effect was limited to the Mycobacte- rium bovis BCG-susceptible population. The increase in the susceptibility of genetically susceptible mice was directly proportional to the duration of HPA axis activation. Thus, multiple restraint experiences were required to increase the susceptibility of the Bcgj mice. In contrast, we have previously reported that a single restraint experience was sufficient to suppress MHC class II expression by macrophages from the Bcg/ mice (60) .
The failure of HPA axis activation to increase the susceptibility of Bcgr mice was not the result of an unresponsiveness of this strain of mice to HPA axis activation. Thus, activation of the HPA axis resulted in a similar increase in the levels of corticosterone in the plasma of both strains of mice (60) . Additionally, HPA axis activation suppresses the induction of MHC class II expression by macrophages from Bcg' mice (50, 61) . We also found that the HPA activation resulted in a suppressed capacity of macrophages from Bcg' and Bcgj mice to produce TNF-a and N02-following stimulation with rIFN-y and LPS. This observation supports those that have shown that corticosteroids suppress both TNF-a production and the production of reactive nitrogen intermediates (3, 15, 59) .
The suppression of TNF-a and N02 production by macrophages of both Bcgf and Bcgf strains of congenic mice as a result of HPA axis activation appears to indicate that the mechanism(s) of resistance that is controlled by Bcg may not be regulated by glucocorticoid hormones. Our results can also be interpreted as indicating that the production of TNF-a and of N02-may also be independent of Bcg VOL. 61, 1993 ed as a result of HPA axis activation. The data are the production and by comparing the levels of IFN-y produced SD of three separate determinations. The effect of HPA following stimulation of spleen cell cultures with antigen. is significant (P < 0.002).
The role of corticosterone in mediating the effects of HPA axis activation was demonstrated in three ways. First, adrenalectomy abrogated the effect of HPA activation. SecMacrophages from both strains of mice produced ond, implantation of time release pellets, which released uantities of the cytokine and of reactive nitrogen similar levels of corticosterone attained during HPA axis iates. Several reports have also shown that there activation, resulted in an increase in the susceptibility of the pparent differences between the levels of TNF-at Bcgj mice to mycobacterial growth. Finally, treatment of the by macrophages from resistant or susceptible mice Bcgj mice with the glucocorticoid receptor antagonist RU 486 abrogated the effects of HPA axis activation. The effect of corticosteroids on macrophage function has been the subject of considerable investigation. Glucocorti--Control 1 10XRestraint coids have been shown to inhibit cytokine production by macrophages (29, 50) and to suppress MHC class II expression (50, 57) and tumoricidal activity (23) . However, glucocorticoid-mediated effects can also potentiate some macrophage functions. This includes the potentiation of the uptake of opsonized erythrocytes by rIFN-y-stimulated macrophages (57) and the expression of cytokine receptors (49, 54) . Activation of macrophages also results in the up regulation of corticosteroid receptors in macrophages (44, 45) . However, this appears to be similar in a macrophage cell line derived from BALB/c BCG-susceptible mice as well as in macrophages from BCG-resistant C3H/OuJ mice. The positive effects of glucocorticoids have been attributed to glucocorticoid response elements which positively regulate NO, (UM) gene expression. In contrast, no consensus regulatory se-HPA axis activation suppresses the production of reacquences that account for the negative regulatory effects of ,en intermediates by macrophages from BALB/c.Bcg' and the glucocorticoids have been identified (2) . lcg' mice. Supernatants from cultures were obtained as
The role of HPA axis activation in controlling the growth in the legend to Fig. 7 , and the production of reactive of tuberculosis in humans has been the subject of some itermediates was determined with the Griess reagent (28) . discussion (11, 24, 58 (8, 14) . This suppression may be particularly apparent in individuals that are innately susceptible to mycobacterial disease and may account for the increase in the incidence of active tuberculosis among susceptible populations. Other cofactors such as homelessness, malnutrition, and chronic alcoholism, as well as stressful life events (7, 11, 16, 22, 24, 26, 27, 33, 35, 37, 39, 58) , may also result in HPA axis activation or activation of the sympathetic nervous system (5, 17, 56) and compound the effects of the disease processes.
